Growth Metrics

Aehr Test Systems (AEHR) Cash & Equivalents (2016 - 2026)

Aehr Test Systems' Cash & Equivalents history spans 17 years, with the latest figure at $36.9 million for Q1 2026.

  • For Q1 2026, Cash & Equivalents rose 25.5% year-over-year to $36.9 million; the TTM value through Feb 2026 reached $36.9 million, up 25.5%, while the annual FY2025 figure was $24.5 million, 50.1% down from the prior year.
  • Cash & Equivalents reached $36.9 million in Q1 2026 per AEHR's latest filing, up from $30.8 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $51.0 million in Q3 2023 to a low of $17.2 million in Q1 2023.
  • Average Cash & Equivalents over 5 years is $34.0 million, with a median of $32.0 million recorded in 2022.
  • Peak YoY movement for Cash & Equivalents: surged 587.12% in 2022, then crashed 50.1% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $18.9 million in 2022, then surged by 167.64% to $50.5 million in 2023, then crashed by 36.22% to $32.2 million in 2024, then dropped by 4.29% to $30.8 million in 2025, then grew by 19.7% to $36.9 million in 2026.
  • Per Business Quant, the three most recent readings for AEHR's Cash & Equivalents are $36.9 million (Q1 2026), $30.8 million (Q4 2025), and $22.7 million (Q3 2025).